MTOR and breast carcinoma: SOX2 has been illustrated to increase cellular proliferation, colony formation, and metastasis by promoting WNT/β-catenin signaling and epithelial-mesenchymal transition (EMT) and downregulating AMP-activated protein kinase/mTOR signaling in breast cancer cells.